Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 13

Results For "ISA"

1403 News Found

Apollo TeleHealth expands integrated healthcare services to Sri City in Tamil Nadu
Hospitals | April 30, 2026

Apollo TeleHealth expands integrated healthcare services to Sri City in Tamil Nadu

New medical and wellness centre combines on-site care with telehealth to support industrial workforce and surrounding communities


India–New Zealand FTA elevates AYUSH systems to global stage with dedicated traditional medicine framework
Policy | April 30, 2026

India–New Zealand FTA elevates AYUSH systems to global stage with dedicated traditional medicine framework

Landmark agreement opens market access, mobility pathways, and institutional collaboration for Ayurveda, Yoga, and holistic healthcare services


OneSource Pharma, Dr Reddy’s secure Health Canada nod for generic Semaglutide
Drug Approval | April 29, 2026

OneSource Pharma, Dr Reddy’s secure Health Canada nod for generic Semaglutide

Approval for generic Semaglutide Injection strengthens CDMO partnership, enabling scalable supply from OneSource’s US FDA-approved Bengaluru facility


Apollo launches its 76th hospital, boosts tech-led healthcare in India
Hospitals | April 28, 2026

Apollo launches its 76th hospital, boosts tech-led healthcare in India

Hyderabad based 400-bed facility brings AI-driven care, advanced imaging, and integrated clinical systems under one roof


Sun Pharma eyes biosimilars-led growth, Organon deal to build $12.4 billion global platform
News | April 28, 2026

Sun Pharma eyes biosimilars-led growth, Organon deal to build $12.4 billion global platform

On the generics and biosimilars front, the combined business is expected to benefit from Sun’s portfolio of more than 550 approved ANDAs across multiple dosage forms


AbbVie seeks FDA nod for subcutaneous SKYRIZI induction in Crohn’s disease
Drug Approval | April 28, 2026

AbbVie seeks FDA nod for subcutaneous SKYRIZI induction in Crohn’s disease

The submission is backed by positive results from the Phase 3 AFFIRM study


Indian Immunologicals clocks all-time high revenue of Rs 1,586 crore in FY26
Biopharma | April 27, 2026

Indian Immunologicals clocks all-time high revenue of Rs 1,586 crore in FY26

Over the past decade, IIL has maintained a strong growth trajectory, registering a compound annual growth rate (CAGR) of 16%


Wellness travel is moving closer to home: What’s driving the shift?
Opinion | April 27, 2026

Wellness travel is moving closer to home: What’s driving the shift?

India leads the shift as wellness tourism integrates healthcare, hospitality, and lifestyle


Huwel Lifesciences, ASMS expand into Southeast Asia with Singapore partner
Supply Chain | April 27, 2026

Huwel Lifesciences, ASMS expand into Southeast Asia with Singapore partner

Collaboration to drive diagnostics exports, tap high-growth regional markets and build scalable commercialization platform


Tata AIA launches ‘Shubh Health Criti’ blending life cover with wellness and investments
Healthcare | April 27, 2026

Tata AIA launches ‘Shubh Health Criti’ blending life cover with wellness and investments

New plan integrates critical illness protection, market-linked health fund and preventive care platform for holistic financial and health security